Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses

C Nicoara, K Zäch, D Trachsel… - Clinical Diagnostic …, 1999 - Am Soc Microbiol
The decay of maternally derived antibodies to measles, mumps, and rubella viruses in Swiss
infants was studied in order to determine the optimal time for vaccination. A total of 500 …

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years

CE Johnson, ML Kumar, JK Whitwell… - The Pediatric …, 1996 - journals.lww.com
Background Since 1989 the American Academy of Pediatrics and the ACIP have
recommended a second dose of measles-mumps-rubella vaccine (MMR®-II) at either school …

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

P Albrecht, FA Ennis, EJ Saltzman, S Krugman - The Journal of pediatrics, 1977 - Elsevier
A serologic study was made in 34 children immunized against measles at the age of 12
months. Using a sensitive virus neutralization test, it was found that many of the children had …

Duration of immunity to measles, rubella and mumps during the first year of life

MJ Cilleruelo, A Fernández-García, S Villaverde… - Vaccine, 2019 - Elsevier
Introduction and objectives The MMR vaccine was included in the official vaccination
schedule in Spain in 1981. Currently, most women of childbearing age are vaccinated and …

Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage

S Waaijenborg, SJM Hahné, L Mollema… - The Journal of …, 2013 - academic.oup.com
Background. The combined measles, mumps, and rubella (MMR) vaccine has been
successfully administered for> 20 years. Because of this, protection by maternal antibodies …

Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence …

LA Mitchell, AJ Tingle, D Décarie… - Canadian journal of public …, 1998 - Springer
Measles, mumps, and rubella-specific IgG antibodies were evaluated in 134 healthy infants
routinely immunized with trivalent live attenuated measles-mumps-rubella (MMR) vaccine at …

Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel

R Dagan, PE Slater, P Duvdevani… - The Pediatric …, 1995 - journals.lww.com
The introduction of live attenuated measles vaccine in Israel during 1967 dramatically
decreased the incidence of measles. However, cases still occur in periodic outbreaks and …

[HTML][HTML] Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up

S Carryn, M Feyssaguet, M Povey, E Di Paolo - Vaccine, 2019 - Elsevier
Measles and mumps outbreaks still occur in countries that have successfully implemented
universal routine immunization programs. Measles outbreaks are mostly associated to …

Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillance

RG Pebody, NJ Gay, LM Hesketh, A Vyse… - Vaccine, 2002 - Elsevier
Measles and mumps, but not rubella, outbreaks have been reported amongst populations
highly vaccinated with a single dose of measles–mumps–rubella (MMR) vaccine. Repeated …

Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose

S Carazo Perez, G De Serres, A Bureau… - Clinical Infectious …, 2017 - academic.oup.com
Background The effect of age at first dose on the immunogenicity of a 2-dose pediatric
schedule of measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) …